Overexpression of Human Chorionic Gonadotropin Causes Multiple Reproductive Defects in Transgenic Mice1
- 1 July 2003
- journal article
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 69 (1) , 338-346
- https://doi.org/10.1095/biolreprod.102.013953
Abstract
Human CG is a pregnancy marker secreted by the placenta, and it utilizes the same receptors as does LH. Human CG is a heterodimer, and its subunits are expressed in tissues other than placenta. Similarly, LH/hCG receptors are also expressed in multiple tissues; however, the physiological significance of this expression is unknown. Free hCGbeta is efficiently secreted in vitro in transfected cells and is highly expressed in many human cancers; however, the biological effects of free hCGbeta in vivo are unknown. To study in vivo consequences of elevated levels of free hCGbeta and hCG dimer in both male and female reproductive physiology, we used mouse metallothionein 1 promoter to generate multiple lines of transgenic mice that overexpressed either one or both subunits of hCG. Although mice expressing the glycoprotein hormone alpha subunit are normal and fertile, both male and female transgenic mice overexpressing only the hormone-specific hCGbeta subunit are infertile. The hCGbeta subunit-expressing transgenic female mice progressively develop cystic ovaries, whereas the male transgenic mice are infertile but otherwise are not phenotypically discernible. In contrast, both the male and female transgenic mice coexpressing high levels of the hCG subunits (i.e., the hCG dimer) demonstrate multiple reproductive defects. The male transgenic mice have Leydig cell hyperplasia, very high levels of serum testosterone, reduced testis size, and dramatically enlarged seminal vesicles and are infertile and display overly aggressive behavior when caged with females. The female transgenic mice are also infertile, have elevated levels of serum estradiol, and progressively develop hemorrhagic and cystic ovaries with thecal layer enlargement and stromal cell proliferation and degenerating kidneys. These results suggest that the in vivo biological effects of ectopically expressed free hCGbeta subunit are distinct from those of the hCG dimer and are gender specific. These transgenic mice are useful models for studying the biology of free hCGbeta subunit, for further analyzing the gain of function effects of hCG during early Leydig cell development, and for studying the roles of hCG in ovarian and kidney pathophysiology and function.Keywords
This publication has 36 references indexed in Scilit:
- Evolution of Lutropin to Chorionic Gonadotropin Generates a Specific Routing Signal for Apical Release in VivoJournal of Biological Chemistry, 2002
- An Overview of the Past, Present, and Future of Nongonadal LH/hCG Actions in Reproductive Biology and MedicineSeminars in Reproductive Medicine, 2001
- Multiple novel roles of luteinizing hormoneFertility and Sterility, 2001
- Novel recombinant gonadotropinsTrends in Endocrinology & Metabolism, 2001
- The Effect of a Null Mutation in the Follicle-Stimulating Hormone Receptor Gene on Mouse Reproduction1Endocrinology, 2000
- Impairing follicle-stimulating hormone (FSH) signalingin vivo: Targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalanceProceedings of the National Academy of Sciences, 1998
- Antitumor effects of hCG in KSNature Biotechnology, 1998
- Follicle stimulating hormone is required for ovarian follicle maturation but not male fertilityNature Genetics, 1997
- The Effects of Preparations of Human Chorionic Gonadotropin on AIDS-Related Kaposi's SarcomaNew England Journal of Medicine, 1996
- The Biological Role of the Carboxyl-Terminal Extension of Human Chorionic Gonadotroin β-SubunitEndocrinology, 1990